MYCN and neoplasm: Enforced expression of wild-type (WT) NUDT1, but not the hydrolase-inactive mutant (E56A)8, efficiently reversed the viability of MYCN-amplified Kelly cells (Fig. 1i), arguing that the catalytic activity of NUDT1 is required for tumor cells to adapt to MYC-driven metabolic reprogramming.